Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Holders of 5% or more of OCUL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ocular Therapeutix, Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%31.8M shares | +2.70 ppfrom 12.30% | Jul 8, 20252 filings | Nov 5, 2025 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G/A | 7.30%12.9M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Deep Track Capital, LP | 13G/A | 6.18%13.1M shares | −3.47 ppfrom 9.65% | May 15, 20252 filings | Nov 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 5.80%10.2M shares | – | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
| Summer Road LLC | 13G | 5.70%12.1M shares | New | Dec 8, 20251 filing | Dec 8, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Ocular Therapeutix, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 202611:06 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Dec 8, 20258:12 PM ET | Summer Road LLC | 13G | 5.70%12.1M shares | New | Dec 4, 2025 | SEC |
| Nov 14, 20255:34 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 7.30%12.9M shares | – | Sep 30, 2025 | SEC |
| Nov 14, 20258:20 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.18%13.1M shares | −3.47 ppfrom 9.65% | Sep 30, 2025 | SEC |
| Nov 5, 202511:40 AM ET | FMR LLCand 1 other | 13G/A | 15.00%31.8M shares | +2.70 ppfrom 12.30% | Sep 30, 2025 | SEC |
| Oct 17, 20256:24 PM ET | BlackRock, Inc. | 13G/A | 5.80%10.2M shares | – | Sep 30, 2025 | SEC |
| Jul 8, 20259:07 AM ET | FMR LLCand 1 other | 13G | 12.30%19.6M shares | New | Jun 30, 2025 | SEC |
| May 15, 20258:45 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 9.65%15.5M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20256:46 AM ET | Opaleye Management Inc. | 13G/A | 2.76%4.34M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ocular Therapeutix, Inc shares.
No Form 144 notices for Ocular Therapeutix, Inc are on file.